DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...

A small study funded by Dexcom, another major CGM manufacturer ... there's no oversight from a doctor or a dietitian to interpret that information and add clarity to it.” This, she says, could lead ...

Real-world data showed reductions in healthcare resource utilization and improved glycemic control over 1 year with ...

We recently published a list of 16 Best Mid Cap Growth Stocks To Buy Now. In this article, we are going to take a look at ...

Iovance's FDA-approved cell therapy for melanoma and the financial uncertainties affect its stock and long-term viability.